CJ Bioscience to Showcase Preclinical Data for CJRB-201 at ECCO 2025 CJ Bioscience is set to present preclinical findings for its promising drug candidate CJRB-201 targeting inflammatory bowel disease at ECCO 2025 in Berlin.

CJ Bioscience to Showcase Preclinical Data for CJRB-201 at ECCO 2025 #South_Korea #Seoul #CJRB-201 #CJ_Broscience #ECCO2025